Rossi Phd News Today

The introduction of pharmaceutical manufacturing quality ratings by the FDA under its Quality Management Maturity (QMM) programme has the potential to reduce drug shortages and improve pharmaceutical company financial performance. Here, Dr Clifford Rossi of the University of Maryland explains.

A recent empirical study of continuous manufacturing (CM) versus batch processing of US and non‑US pharmaceutical manufacturing facilities suggests that CM would be more economical than batch facilities, at least for the production of oral solid dosage products. Dr Clifford Rossi explains more...